Isentress (raltegravir) / Merck (MSD)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isentress (raltegravir) / Merck (MSD)
POPARV, NCT03194165: Population Pharmacokinetics of Antiretroviral in Children

Completed
N/A
65
Europe
Dolutegravir, Raltegravir, Rilpivirine, Nevirapine, Atazanavir, Darunavir, Ritonavir
Assistance Publique - Hôpitaux de Paris
Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed
06/22
06/22
RalAge2, NCT03579485: An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)

Recruiting
N/A
90
Europe
Azienda Policlinico Umberto I
Hiv
12/23
12/24
EPPICC, NCT05751031: Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration

Recruiting
N/A
1200
Europe, RoW
Raltegravir
Fondazione Penta UK, UCL Great Ormond Street Institute of Child Health
HIV Infections
02/24
02/24
NCT00537966: Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study

Recruiting
N/A
2017
Europe
Dolutegravir, Tivicay, Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate, Genvoya, Raltegravir, isentress, Darunavir, Prezista, Ritonavir, Norvir, Rilpivirine, Edurant, Lamivudine, 3TC, tenofovir, Viread, Emtricitabine, Emtriva, Abacavir, Ziagen
University of Zurich
HIV Infections
01/25
01/25

Download Options